Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03238794 · ClinicalTrials.gov registry record · NA

Bariatric Surgery Versus Diet Alone in the Bile Acid Pathway and Weight Loss

A NA study of Obesity, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT03238794: Active NA study of Obesity, sponsored by Mayo Clinic.

NCT03238794 is a NA study of Obesity that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 21 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03238794, a NA study of Obesity, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

It is unknown whether the bile acid pathway reacts differently to weight loss resulting from Roux-En-Y Gastric Bypass (RYGB) surgery than weight loss resulting from caloric restriction alone.

Conditions Studied

Interventions

  • PROCEDURE Roux-En-Y Gastric Bypass
  • OTHER Low-calorie Diet

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2019-05-17
Est. Completion 2027-01-11
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03238794

The ClinicalTrials.gov registry entry for NCT03238794 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Roux-En-Y Gastric Bypass is the first listed.

NCT03238794 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03238794 about?

NCT03238794 is a clinical study titled "Bariatric Surgery Versus Diet Alone in the Bile Acid Pathway and Weight Loss". It is unknown whether the bile acid pathway reacts differently to weight loss resulting from Roux-En-Y Gastric Bypass (RYGB) surgery than weight loss resulting from caloric restriction alone.

What is the current status of trial NCT03238794?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2019-05-17. Estimated completion is 2027-01-11.

What conditions does trial NCT03238794 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03238794?

The interventions under investigation include: Roux-En-Y Gastric Bypass (PROCEDURE), Low-calorie Diet (OTHER).

Who is sponsoring clinical trial NCT03238794?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03238794 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.